Historical Valuation
P3 Health Partners Inc (PIII) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.02 is considered Undervalued compared with the five-year average of -5.97. The fair price of P3 Health Partners Inc (PIII) is between 22.49 to 68.37 according to relative valuation methord. Compared to the current price of 3.48 USD , P3 Health Partners Inc is Undervalued By 84.53%.
Relative Value
Fair Zone
22.49-68.37
Current Price：3.48
84.53%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
P3 Health Partners Inc (PIII) has a current Price-to-Book (P/B) ratio of 0.00. Compared to its 3-year average P/B ratio of -3.38 , the current P/B ratio is approximately -100.00% higher. Relative to its 5-year average P/B ratio of -2.39, the current P/B ratio is about -100.00% higher. P3 Health Partners Inc (PIII) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -145.07%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -98.85% , the current FCF yield is about -100.00% lower.
P/B
Median3y
-3.38
Median5y
-2.39
FCF Yield
Median3y
-145.07
Median5y
-98.85
Competitors Valuation Multiple
AI Analysis for PIII
The average P/S ratio for PIII competitors is 0.54, providing a benchmark for relative valuation. P3 Health Partners Inc Corp (PIII.O) exhibits a P/S ratio of 0.02, which is -96.14% above the industry average. Given its robust revenue growth of -3.93%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for PIII
1Y
3Y
5Y
Market capitalization of PIII increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of PIII in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is PIII currently overvalued or undervalued?
P3 Health Partners Inc (PIII) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.02 is considered Undervalued compared with the five-year average of -5.97. The fair price of P3 Health Partners Inc (PIII) is between 22.49 to 68.37 according to relative valuation methord. Compared to the current price of 3.48 USD , P3 Health Partners Inc is Undervalued By 84.53% .
What is P3 Health Partners Inc (PIII) fair value?
PIII's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of P3 Health Partners Inc (PIII) is between 22.49 to 68.37 according to relative valuation methord.
How does PIII's valuation metrics compare to the industry average?
The average P/S ratio for PIII's competitors is 0.54, providing a benchmark for relative valuation. P3 Health Partners Inc Corp (PIII) exhibits a P/S ratio of 0.02, which is -96.14% above the industry average. Given its robust revenue growth of -3.93%, this premium appears unsustainable.
What is the current P/B ratio for P3 Health Partners Inc (PIII) as of Jan 09 2026?
As of Jan 09 2026, P3 Health Partners Inc (PIII) has a P/B ratio of 0.00. This indicates that the market values PIII at 0.00 times its book value.
What is the current FCF Yield for P3 Health Partners Inc (PIII) as of Jan 09 2026?
As of Jan 09 2026, P3 Health Partners Inc (PIII) has a FCF Yield of 0.00%. This means that for every dollar of P3 Health Partners Inc’s market capitalization, the company generates 0.00 cents in free cash flow.
What is the current Forward P/E ratio for P3 Health Partners Inc (PIII) as of Jan 09 2026?
As of Jan 09 2026, P3 Health Partners Inc (PIII) has a Forward P/E ratio of -0.33. This means the market is willing to pay $-0.33 for every dollar of P3 Health Partners Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for P3 Health Partners Inc (PIII) as of Jan 09 2026?
As of Jan 09 2026, P3 Health Partners Inc (PIII) has a Forward P/S ratio of 0.02. This means the market is valuing PIII at $0.02 for every dollar of expected revenue over the next 12 months.